DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2015.
In the second quarter net revenue grew 3.4% year on year to $388.7 million from $376 million in the same quarter last year. This represented 9% constant currency growth and 4% constant dollar organic growth year on year.
Income from operations increased by 41% to $68.1 million or 17.5% of revenue compared to $48.3 million or 12.8% for the same quarter last year.
Help employers find you! Check out all the jobs and post your resume.
